BIO Unveils Seven-Point Plan to Secure America’s Leadership in the Biotech Century

Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strength

WASHINGTON (November 10, 2026) - The Biotechnology Innovation Organization (BIO) today unveiled BioAdvance: Securing America’s Biotech Century, a seven-point plan to strengthen America’s biotechnology leadership amid intensifying global competition from China. The action plan calls for a coordinated national strategy and targeted policy reforms to accelerate medical breakthroughs, strengthen America’s innovation ecosystem, and ensure the next generation of lifesaving medicines is developed and manufactured in the United States.

“For decades, American biotechnology innovators have turned scientific discovery into hope for patients and families, building an industry that saves lives, drives economic growth, and strengthens our nation’s security and competitiveness,” said John F. Crowley, president and CEO of BIO. “In doing so, America’s biotechnology innovators have built one of our nation’s greatest strategic assets. But our leadership is not guaranteed. We must invest, innovate, and act with urgency.”

America’s strength in biotechnology is reflected in the industry’s scientific and economic reach. In 2025, the U.S. bioscience industry employed more than 2.3 million Americans across more than 156,000 business establishments and generated nearly $3.2 trillion in total economic output.

Today, America’s competitive advantage faces mounting pressure. China now launches more than a quarter of the world’s clinical trials and conducts early-stage studies faster and at lower cost than the United States.  

Momentum is building in Washington to meet that challenge. BioAdvance seeks to channel that momentum into a coordinated national strategy. The plan outlines seven actionable priorities across three areas:

Coordinate: Establish a clear national strategy for U.S. biotech leadership

• Establish a White House Office of Biotechnology.

Accelerate: Bring lifesaving discoveries to patients faster

• Speed up the path to first-in-human clinical studies.
• Modernize and streamline drug development.
• Improve patient access to clinical trials.

Build: Strengthen the foundations of American biotechnology

• Sustain support for biomedical research.
• Expand U.S. biomanufacturing capacity and expertise.
• Strengthen intellectual property protections and access to capital.

“This moment demands the ambition and determination that catalyzed the biotechnology revolution and made America the definitive global leader,” Crowley added. “BIO stands ready to work with the administration, Congress, and the entire biotechnology ecosystem to accelerate the next generation of lifesaving breakthroughs, and ensure the United States leads the biotech century.”

Read BioAdvance: Securing America’s Biotech Century and the accompanying summary at bio.org/bioadvance.

###